Table 5 GLS (%) parameters per vessel

Rest

−21.86 ± 3.09

−23.20 ± 2.87

0.03

Peak dose

−16.38 ± 5.76

−24.96 ± 4.42

<0.001

Delta

−5.46 ± 5.27

1.76 ± 3.77

<0.001

LCX disease (+)

LCX disease (−)

Rest

−19.80 ± 3.16

−21.70 ± 2.88

0.01

Peak dose

−16.13 ± 4.53

−23.43 ± 3.69

<0.001

Delta

−3.59 ± 4.91

1.51 ± 4.14

<0.001

RCA disease (+)

RCA disease (−)

Rest

−18.73 ± 3.052

−20.23 ± 2.87

0.04

Peak dose

−15.69 ± 5.96

−22.11 ± 4.21

<0.001

Delta

−3.47 ± 5.22

1.65 ± 4.17

<0.001

LCX-RCA disease (+)

LCX-RCA disease (−)

Rest

−19.28 ± 2.10

−20.29 ± 2.33

0.03

Peak dose

−16.43 ± 5.30

−22.42 ± 3.95

<0.001

Delta

−2.83 ± 5.11

2.18 ± 3.95

<0.001